Spyre Therapeutics Plans $350M Stock Offering, Shares Fall
Shares of Spyre Therapeutics declined 12% to $81.83 after the company announced plans to sell $350 million worth of stock in a public offering.
Spyre Therapeutics said it will sell $350 million worth of stock in a public offering, sending shares lower. 83 as of midday Tuesday. Shares have gained around one-and-a-half times their value this year. The biotechnology company said it will offer…